Lung Cancer Drug Resistance Controlled by microRNA Expression

The development of drug resistance is an ongoing problem in the treatment of lung cancer. New research finds that lung cancer cells can transition between drug-sensitive and drug-resistant “states.” The findings also suggest that the states can be controlled by the expression of the microRNA miR-335. Understanding how resistance arises in lung cancer is key to developing novel, more effective, treatments.